Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Medigene buys cancer vaccine start-up

Acquires Trianta to boost immuno-oncology business

- PMLiVE

Pfizer beats earnings estimates as new products grow

Lyrica, Inlyta and Xalkori help offset generic competition

- PMLiVE

Pharma companies differ on Sunshine Act payment definition

Confusion about whether provision of editorial services is transfer of value

- PMLiVE

WHO appoints two regional directors

Dr Poonam Khetrapal Singh and Dr Shin Young-soo to head major areas

The thing about small numbers

Marketers working in orphan drugs need to take a narrower, deeper approach to relationship building, and look to medical centres of excellence

- PMLiVE

Going off-label?

There’s a thin line between the legitimate and fraudulent 'off-label' promotion, as a recent US court case highlights

- PMLiVE

Pharma’s digital directions in 2014

Multi-channel marketing a priority, but mobile websites may be neglected

- PMLiVE

CHMP turns down drugs for MS, cancer and muscular dystrophy

Negative EU recommendations for Teva, AB Science and PTC Therapeutics

China flag thumb

Actavis divests another Chinese interest

Reduces presence in “risky” market

- PMLiVE

Blow to Pfizer as dacomitinib fails in lung cancer trials

Unable to demonstrate improved survival in patients

- PMLiVE

NICE backs Astellas’ Xtandi in prostate cancer

But company criticises restrictions imposed by HTA body for England

- PMLiVE

ASA bans two Botox ads

Dermaskin Clinics and HB Health forced to remove promotions from website homepages

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links